NCT04991454View on ClinicalTrials.gov

Xenon MRI Pulm Hypertension

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

August 30, 2026

Study Completion Date

August 30, 2026

Conditions
Pulmonary HypertensionPulmonary Arterial Hypertension
Interventions
DRUG

129Xe Hyperpolarized

Each xenon dose will be limited to a volume less than 25% of subject lung capacity (TLC), as is the case for all protocols currently carried out under IND 109,490.

Trial Locations (1)

27710

RECRUITING

Duke University Medical Center, Durham

All Listed Sponsors
lead

Bastiaan Driehuys

OTHER